2015 Spring ADRC Meeting presentations

For a PDF of the overall session's agenda, click the session name (e.g., DIRECTORS MEETING).
For an individual presentation, click the presentation title.

Administrators Meeting

Administrators Meeting
Public/private partnerships in research: Perspectives from the Foundation for the National Institutes of Health
Rosa Canet-Aviles, PhD; Scientific Program Manager, Neuroscience, FNIH
Initial development and research applications of PET tau imaging with 18F-AV-1451 (aka 18F-T807)
Mark A. Mintun, MD; Chief Medical Officer, Avid Radiopharmaceuticals
Continuous in-home assessment: New approaches to assessing health
Jeffrey Kaye, MD; Director, Oregon Health & Science University
The not-so-grim RPPR
Cerise Elliott, PhD; Research Program Analyst, Division of Neuroscience, NIA/NIH
Krista Moulder, PhD (panel chair); Associate Administrator, Washington University in St. Louis
Mary Sundsmo, MBA; Administrator, University of California, San Diego
Sleep disorders most pertinent to dementia research: RBD and OSA
Bradley Boeve, MD; Clinical Core Co-Leader, Mayo Clinic
Panel: How do we get it all done? By "standing on the shoulders" of …
Panel: How do we get it all done? By "standing on the shoulders" of …
Senior volunteers in the community
Anne Arthur, APRN, BC; Administrator, University of Kansas
Undergraduate summer interns
Amanda Burden, BA (panel chair); Administrator, Mount Sinai
Apps and technology
Maggie Dean, BS; Research Manager, National Alzheimer's Coordinating Center
The people all around you
Bradley Glazier; Administrator, Indiana University

Directors Meeting

Directors Meeting
NIA update
Richard Hodes, MD; Director, NIA
NACC and UDS3 update
Walter A. Kukull, PhD; Director, National Alzheimer's Coordinating Center
ADGC update
Gerard Schellenberg, PhD; P.I., Alzheimer's Disease Genetics Consortium
NIAGADS update
Gerard Schellenberg, PhD (for Li-San Wang, PhD; P.I., NIAGADS)
NCRAD update
Tatiana Foroud, PhD; P.I., National Cell Repository for Alzheimer's Disease
Scientific symposium: Discovery of therapeutics
Alzheimer's Prevention Initiative
Eric Reiman, MD; Director, Arizona ADRC
Intranasal insulin and Alzheimer’s disease: Diversifying the AD therapeutic portfolio
Suzanne Craft, PhD; Project 2 Leader, University of Washington
Targeting the p75 receptor to inhibit AD degenerative signaling and tau phosphorylation/ misfolding/ missorting: preclinical through phase 1
Frank Longo, MD; Director, Stanford University
Small-molecule modulation of CD33
Elizabeth Bradshaw, PhD; Brigham and Women's Hospital

Clinical Core Leaders Meeting

Clinical Core Leaders Meeting presentations
What should we do until we have a prevention for AD? Practices and investigational approaches to symptom management
Steven E. Arnold, MD; Chair, Clinical Core Leaders Steering Committee
Pharmacological approaches for cognition
Martin R. Farlow, MD; Clinical Core Leader, Indiana University
Physical exercise and non-pharamacological approaches for cognition
Laura D. Baker, PhD; Associate Professor, Wake Forest University
Maximizing independence (MIND) at home and community-based dementia care coordination
Constantine Lyketsos, MD; Clinical Core Leader, Johns Hopkins University
Prazosin for agitation management in dementia
Murray A. Raskind, MD; ORE Core Leader, University of Washington